Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NEDD4-binding protein 3 (N4BP3) is a cytoplasmic adaptor protein and a member of the Fezzin family, characterized by a coiled-coil domain, a C-terminal Fez1 domain, and a highly conserved PY (PPxY) motif that mediates selective binding to the WW domains of the ubiquitin ligase NEDD4[1]. N4BP3 is expressed prominently in neural tissues including axons, dendrites, and growth cones, where it plays a crucial role in the proper branching and arborization of neuronal processes during development[1][3][6]. Loss of N4BP3 leads to abnormal axonal and dendritic morphology both in vitro and in vivo, suggesting it is essential for correct neural circuit formation[1]. Beyond neurodevelopment, N4BP3 has been shown to positively regulate antiviral innate immunity by interacting with MAVS (mitochondrial antiviral-signaling protein) to promote RIG-I-like receptor signaling and type I interferon production[5][3][6]. N4BP3 does not appear to function as an enzyme, receptor, transporter, or classical transcription factor, but rather as a modulator or adaptor protein collaborating with enzymes such as NEDD4. Although it is grouped with leucine zipper putative tumor suppressors (LZTS), its specific roles in cancer biology remain poorly understood. No approved or investigational drugs currently target N4BP3 directly, and it is not used clinically as a biomarker or established therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NEDD4-binding protein 3 (N4BP3).